Warburg effect or reverse warburg effect? a review of cancer metabolism

Oncology Research and Treatment

Volumn 38, Issue 3, 2015, Pages 117-122

  Xu, Xiao Dong ^a   Shao, Shi Xiu ^a   Jiang, Hai Ping ^a   Cao, Yan Wei ^a   Wang, Yong Hua ^a   Yang, Xue Cheng ^a   Wang, You Lin ^a   Wang, Xin Sheng ^a   Niu, Hai Tao ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Cell transformation, neoplastic; Energy metabolism; Glycolysis

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLYCOGEN; LACTIC ACID;

ACIDOSIS; CANCER CELL; CELL METABOLISM; CELL TRANSFORMATION; FIBROBLAST; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; METABOLIC REGULATION; METABOLISM; MITOCHONDRION; NEOPLASM; OXIDATIVE PHOSPHORYLATION; REVIEW; WARBURG EFFECT; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; GLYCOLYSIS; HUMANS; NEOPLASMS;

EID: 84925358499     PISSN: 22965270     EISSN: None     Source Type: Journal    
DOI: 10.1159/000375435     Document Type: Review

References (43)

1. Warburg O: The metabolism of carcinoma cells. J Cancer Res1925; 9: 148-163.
2. Cori CF, Cori GT: The carbohydrate metabolism of tumors II. Changes in the sugar, lactic acid, and CO2-combining power of blood passing through a tumor. J Biol Chem 1925; 65: 397-405.
3. Warburg O, Minami S: Tests on surviving carcinoma cultures. Biochem Z 1923; 142: 317-333.
4. Gatenby RA, Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-899.
5. Ferreira LMR: Cancer metabolism: The Warburg effect today. Exp Mol Pathol 2010; 89: 372-380.
6. Pauwels EK, Sturm EJ, Bombardieri E, et al.: Positronemission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 2000; 126: 549-559.
7. Hsu PP, Sabatini DM: Cancer cell metabolism: Warburg and beyond. Cell 2008; 134: 703-707.
8. Stern R, Shuster S, Neudecker BA, Formby B: Lactate stimulates fibroblast expression of hyaluronan and CD44:the Warburg effect revisited. Exp Cell Res 2002; 276: 24-31.
9. Fischer K, Hoffmann P, Voelkl S, et al.: Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 2007; 109: 3812-3819.
10. Erecińska M, Deas J, Silver IA: The effect of pH on glycolysis and phosphofructokinase activity in cultured cells and synaptosomes. J Neurochem 1995; 65: 2765-2772.
11. Lopez-Lazaro M: The Warburg effect: Why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med Chem 2008; 8: 305-312.
12. Samudio I, Fiegl M , Andreeff M: Mitochondrial uncoupling and the Warburg effect: Molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 2009; 69: 2163-2166.
13. Derdak Z, Mark NM, Beldi G, et al.: The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. Cancer Res 2008; 68: 2813-2819.
14. Weinhouse S: On respiratory impairment in cancer cells. Science 1956; 124: 267-269.
15. Zhou Y, Liu S: 64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging. Bioconjug Chem 2011; 22: 1459-1472.
16. Lieberman BP, Ploessl K, Wang L, et al.: PET imaging of glutaminolysis in tumors by 18F-(2S, 4R) 4-fluoroglutamine. J Nucl Med 2011; 52: 1947-1955.
17. Zu XL, Guppy M: Cancer metabolism: Facts, fantasy, and fiction. Biochem Biophys Res Commun 2004; 313: 459-465.
18. Martinez-Outschoorn UE, Lin Z, Trimmer C, et al.: Cancer cells metabolically fertilize the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: Implications for PET imaging of human tumors. Cell Cycle 2011; 10: 2504-2520.
19. Mandujano-Tinoco EA, Gallardo-Pérez JC, Marín-Hernández A, et al.: Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids. Biochim Biophys Acta 2013; 1833: 541-551.
20. Mazurek S, Eigenbrodt E: The tumor metabolome. Anticancer Res 2003; 23: 1149-1154.
21. Fan TWM, Kucia M, Jankowski K, et al.: Rhabdomyosarcoma cells show an energy producing anabolic metabolic phenotype compared with primary myocytes. Mol Cancer 2008; 7: 79.
22. Dang L, Jin S, Su SM: Mutations in glioma and acute myeloid leukemia. Trends Mol Med 2010; 16: 387-397.
23. Mullen AR, Wheaton WW, Jin ES, et al.: Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2011; 481: 385-388.
24. Scandurra FM, Gnaiger E: Cell respiration under hypoxia: Facts and artefacts in mitochondrial oxygen kinetics. Adv Exp Med Biol 2010; 662: 7-25.
25. Horan AD, Koch CJ: The Km for radiosensitization of human tumor cells by oxygen is much greater than 3 mmHg and is further increased by elevated levels of cysteine. Radiat Res 2001; 156: 388-398.
26. Erickson K, Braun RD, Yu D, et al.: Effect of longitudinal oxygen gradients on effectiveness of manipulation of tumor oxygenation. Cancer Res 2003; 63: 4705-4712.
27. Kobayashi S, Millhorn DE: Hypoxia regulates glutamate metabolism and membrane transport in rat PC12 cells. J Neurochem 2001; 76: 1935-1948.
28. Rodríguez-Enríquez S, Gallardo-Pérez JC, Avilés-Salas A, et al.: Energy metabolism transition in multi-cellular human tumor spheroids. J Cell Physiol 2008; 216: 189-197.
29. Rodríguez-Enríquez S, Carreño-Fuentes L, Gallardo-Pérez JC, et al.: Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma. Int J Biochem Cell B 2010; 42: 1744-1751.
30. Rodríguez-Enríquez S, Hernández-Esquivel L, Marín-Hernández A, et al.: Molecular mechanism for the selective impairment of cancer mitochondrial function by a mitochondrially targeted vitamin E analogue. Biochim Biophys Acta 2012; 1817: 1597-1607.
31. Manalo DJ, Rowan A, Lavoie T, et al.: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005; 105: 659-669.
32. Mandujano-Tinoco EA, Gallardo-Pérez JC, Marín-Hernández A, et al.: Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids. Biochim Biophys Acta 2013; 1833: 541-551.
33. Marín-Hernández A, Gallardo-Pérez JC, López-Ramírez SY, et al.: Casiopeina II-gly and bromopyruvate inhibition of tumor hexokinase, glycolysis and oxidative phosphorylation. Arch Toxicol 2012; 86: 753-766.
34. Marín-Hernández A, Gracia-Mora I, Ruiz-Ramírez L, Moreno-Sánchez R: Toxic effects of copper-based antineoplastic drugs (Casiopeinas) on mitochondrial functions. Biochem Pharmacol 2003; 65: 1979-1989.
35. Hernández-Esquivel L, Marín-Hernández A, Pavón N, et al.: Cardiotoxicity of copper-based anti-neoplastic drugs casiopeinas is related to inhibition of energy metabolism. Toxicol Appl Pharmacol 2006; 212: 79-88.
36. Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J: Cancer: A systems biology disease. Biosystems 2006; 83: 81-90.
37. Hornberg JJ, Bruggeman FJ, Bakker BM, Westerhoff HV: Metabolic control analysis to identify optimal drug targets. Prog Drug Res. 2007; 64: 171,173-189.
38. Moreno-Sánchez R, Saavedra E, Rodríguez-Enríquez S, et al.: Metabolic control analysis indicates a change of strategy in the treatment of cancer. Mitochondrion 2010; 10: 626-639.
39. Murabito E, Smallbone K, Swinton J, et al.: A probabilistic approach to identify putative drug targets in biochemical networks. J R Soc Interface 2011; 8: 880-895.
40. Rodriguez-Enriquez S, Torres-Márquez ME, Moreno-Sánchez R: Substrate oxidation and ATP supply in AS-30D hepatoma cells. Arch Biochem Biophys 2000; 375: 21-30.
41. Dalmonte ME, Forte E, Genova ML, et al.: Control of respiration by cytochrome c oxidase in intact cells role of the membrane potential. J Biol Chem 2009; 284: 32331-32335.
42. Quarato G, Piccoli C, Scrima R, Capitanio N: Variation of flux control coefficient of cytochrome c oxidase and of the other respiratory chain complexes at different values of protonmotive force occurs by a threshold mechanism. Biochim Biophys Acta 2011; 1807: 1114-1124.
43. Kaambre T, Chekulayev V, Shevchuk I, et al.: Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer. J Bioenerg Biomembr 2012; 44: 539-558.